Open AccessA Pilot Study of an Oral Phosphodiesterase Inhibitor (Apremilast) for Atopic Dermatitis in Adults
Author(s) -
Aman Samrao,
Trista M. Berry,
Renato Goreshi,
Eric L. Simpson
Publication year - 2012
Publication title -
archives of dermatology
Language(s) - English
Resource type - Journals
eISSN - 1538-3652
pISSN - 0003-987X
DOI - 10.1001/archdermatol.2012.812
Subject(s) - apremilast , medicine , atopic dermatitis , eczema area and severity index , dermatology life quality index , adverse effect , visual analogue scale , randomized controlled trial , quality of life (healthcare) , dermatology , surgery , psoriasis , nursing , psoriatic arthritis
To investigate the preliminary safety and efficacy of apremilast, an oral phosphodiesterase 4 inhibitor, for atopic dermatitis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom